Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Complement activation in astrocytomas: deposition of C4d and patient outcome.

Mäkelä K, Helén P, Haapasalo H, Paavonen T.

BMC Cancer. 2012 Dec 1;12:565. doi: 10.1186/1471-2407-12-565.

2.

Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.

Mäkelä K, Nordfors K, Finne J, Jokilammi A, Paavonen T, Haapasalo H, Korja M, Haapasalo J.

BMC Cancer. 2014 Aug 28;14:623. doi: 10.1186/1471-2407-14-623.

3.

Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.

Faria MH, Gonçalves BP, do Patrocínio RM, de Moraes-Filho MO, Rabenhorst SH.

Neuropathology. 2006 Dec;26(6):519-27.

PMID:
17203587
4.

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.

Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, Vrinda M, Sridevi S, Shailaja BC, Samuel C, Prasanna KV, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Somasundaram K, Kondaiah P, Rao MR.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213.

5.

Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.

Yang I, Han SJ, Sughrue ME, Tihan T, Parsa AT.

J Neurosurg. 2011 Sep;115(3):505-11. doi: 10.3171/2011.4.JNS101172.

PMID:
21663411
6.

Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.

Hiura T, Khalid H, Yamashita H, Tokunaga Y, Yasunaga A, Shibata S.

Cancer. 1998 Dec 1;83(11):2361-9.

PMID:
9840536
7.

Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins.

Camby I, Nagy N, Lopes MB, Schäfer BW, Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi J, Salmon I, Kiss R, Decaestecker C.

Brain Pathol. 1999 Jan;9(1):1-19.

PMID:
9989446
8.

Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.

Shwetha SD, Shastry AH, Arivazhagan A, Santosh V.

Pathol Res Pract. 2016 Jan;212(1):17-23. doi: 10.1016/j.prp.2015.11.002.

PMID:
26616112
9.

Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.

Sato S, Sato Y, Hatakeyama K, Marutsuka K, Yamashita A, Takeshima H, Asada Y.

Histol Histopathol. 2011 Apr;26(4):497-504.

PMID:
21360443
10.

Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.

Mäkelä KS, Haapasalo JA, Ilvesaro JM, Parkkila S, Paavonen T, Haapasalo HK.

Histol Histopathol. 2014 Sep;29(9):1161-8. doi: 10.14670/HH-29.1161.

PMID:
24599602
11.

Altered expression of immune defense genes in pilocytic astrocytomas.

Huang H, Hara A, Homma T, Yonekawa Y, Ohgaki H.

J Neuropathol Exp Neurol. 2005 Oct;64(10):891-901.

12.

Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions.

Khalid H, Tsutsumi K, Yamashita H, Kishikawa M, Yasunaga A, Shibata S.

Cell Mol Neurobiol. 1995 Apr;15(2):257-68.

PMID:
8590455
13.

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.

Tsai WC, Chen Y, Huang LC, Lee HS, Ma HI, Huang SM, Sytwu HK, Hueng DY.

J Neurooncol. 2013 Sep;114(3):281-90. doi: 10.1007/s11060-013-1184-5.

14.

Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.

Goeppert B, Schmidt CR, Geiselhart L, Dutruel C, Capper D, Renner M, Vogel MN, Zachskorn C, Zinke J, Campos B, Schmezer P, Popanda O, Wick W, Weller M, Meyermann R, Schittenhelm J, Harter PN, Simon P, Weichert W, Schirmacher P, Plass C, Mittelbronn M.

J Neuropathol Exp Neurol. 2013 Oct;72(10):933-41. doi: 10.1097/NEN.0b013e3182a59a88.

15.

Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.

Samaras V, Piperi C, Levidou G, Zisakis A, Kavantzas N, Themistocleous MS, Boviatsis EI, Barbatis C, Lea RW, Kalofoutis A, Korkolopoulou P.

Hum Immunol. 2009 Jun;70(6):391-7. doi: 10.1016/j.humimm.2009.03.011.

PMID:
19332096
17.

Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.

Kozlowski T, Andreoni K, Schmitz J, Hayashi PH, Nickeleit V.

Liver Transpl. 2012 Jun;18(6):641-58. doi: 10.1002/lt.23403.

18.

Fascin expression in 90 patients with glioblastoma multiforme.

Roma AA, Prayson RA.

Ann Diagn Pathol. 2005 Dec;9(6):307-11.

PMID:
16308158
19.

Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.

Hunter S, Young A, Olson J, Brat DJ, Bowers G, Wilcox JN, Jaye D, Mendrinos S, Neish A.

J Neuropathol Exp Neurol. 2002 Mar;61(3):275-81.

20.

[Significance of C4d deposition in the follicular lymphoma].

Zheng ZY, Bu XM, Wang C, Xiong XS, Wu ZZ, Yu YH.

Zhonghua Xue Ye Xue Za Zhi. 2007 Apr;28(4):227-9. Chinese.

PMID:
17877197
Items per page

Supplemental Content

Support Center